ARTED Ordinary General Assembly Meeting is held on Thursday, February 15, 2024, at Crowne Plaza Istanbul Oryapark.
The agenda of the Ordinary General Assembly started with the opening speeches. Following the election of the Presidency Board and the reading of the Board of Directors’ activity report, balance sheet and income-expense chart for the previous working period, the 2023 activities of ARTED were evaluated and the activities of the Board of Auditors and the Board of Directors in the last working period were acquitted.
Serhan Acar was elected Chairman of the Board, Gürdal Şahin and Ali Aksoy were elected Vice Chairmen of the Board as a result of the election made during the General Assembly.
ARTED Board of Management and Audit Board for the 2024-2026 period is as follows;
Board of Management
Serhan Acar (ARTED Chairman of the Board) – Boston Scientific
Gürdal Şahin (ARTED Vice Chairman of the Board) – Siemens Healthineers
Ali Aksoy (ARTED Vice Chairman of the Board) – Stryker
Ayhan Öztürk- Medtronic
Yelda Ulu Colin- Abbott
Board of Directors Substitute Members
Ceylan Yokuş – Johnson and Johnson
Nilüfer Özkan – bioMerieux
Ecehan Güvenç – B. Braun
Cem Durukan – Beckman Coulter
Umut Gökalp – Sysmex
Audit Board
Erhan Kemal Eray – Smith and Nephew
Bülent Gezer – Becton Dickinson
Umut Meriç – Alcon
Audit Board Substitute Members
Vecihe Özek – Getinge
Seda Üzün Doyduk – Bayer
Kıvılcım Erdoğan – Bausch and Lomb
We would like to thank Ayhan Öztürk for assuming the position of Chairman of the ARTED Board of Management in the 2019-2023 period. Also thanks to members of the Board of Management and all our members who attended our General Assembly meeting. We congratulate all our representatives who have undertaken new duties.